FIELD: medicine.
SUBSTANCE: invention relates to DNA sequences coding recombinant chimeric proteins, which inhibit angiogenesis; coded by chimeric proteins; their therapeutic application; medicinal composition, containing chimeric proteins. Claimed invention provides medications blocking VEGF and inhibiting angiogenesis, and medicinal compositions containing chimeric proteins and suitable chimeric carriers, and their medicinal form.
EFFECT: efficient therapeutic application of medicinal composition.
13 cl, 6 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FUSED POLYPEPTIDE ABLE FOR BINDING WITH VEGF POLYPEPTIDE AND NUCLEIC ACID MOLECULE ENCODING THEREOF, THEIR PREPARING AND USING | 2000 |
|
RU2265661C2 |
| RECOMBINANT ANTIBODIES AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), OBTAINED BY VARIABLE REGION MUTAGENESIS | 2011 |
|
RU2557309C2 |
| DNA VACCINE AGAINST PROLIFERATING ENDOTHELIAL CELLS AND USES THEREOF | 2003 |
|
RU2318019C2 |
| ACTIVE ANGIOGENESIS-PREVENTING IMMUNETHERAPY | 2003 |
|
RU2329824C2 |
| METHODS OF TREATING CANCER USING PD-1 AXIS BINDING AND VEGF ANTAGONISTS | 2013 |
|
RU2689760C2 |
| COMPOSITION FOR INHIBITION OF ANGIOGENESIS, MONOCLONAL ANTIBODY, POLYPEPTIDE, METHOD OF INHIBITION OF TUMOR GROWTH (VARIANTS) | 1992 |
|
RU2170589C2 |
| FGF-R-Fc FUSED PROTEIN AND USE THEREOF | 2012 |
|
RU2560573C2 |
| INHIBITORS OF RECEPTORS OF TYPE 2 VESSEL ENDOTHELIUM GROWTH FACTOR | 2004 |
|
RU2402567C2 |
| ANTI-ANGIOGENESIS THERAPY USED FOR TREATING BREAST CANCER | 2009 |
|
RU2531948C2 |
| HYBRID PROTEINS BASED ON HUMAN Notch3 AS TRAPS-INHIBITORS OF Notch3 SIGNAL TRANSMISSION | 2009 |
|
RU2567662C2 |
